Jonathan C Fox Insider Profile

4 Followers
Jonathan C Fox, President and Chief Medical Officer at Eidos Therapeutics, holds 23.70K shares in Edgewise Therapeutics (Ticker: EWTX), holds 380.97K shares in Eidos Therapeutics (Ticker: EIDX). Most recently, Jonathan C Fox Bought ― shares of Edgewise Therapeutics on Nov 13, 2025 for an estimated value of $199.34K.
tipranks
Jonathan C Fox

Jonathan C Fox
Eidos Therapeutics (EIDX)
President and Chief Medical Officer

Ranked #100,449 out of 104,310 Corporate Insiders

Profitable Transactions

9%
1 out of 11 Profitable Transactions

Average Return

-51.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$528K
100.00%
A breakdown of Jonathan C Fox's holdings

Insider Roles

Edgewise Therapeutics
(EWTX)
Director
Roles that Jonathan C Fox holds in companies

Most Profitable Insider Trade

Stock:
Edgewise Therapeutics
(EWTX)
Rating:Informative Buy
Date:Dec 28, 2023 - Dec 28, 2024
Return:+149.90%
The most profitable trade made by Jonathan C Fox

Jonathan C Fox's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
EIDX
Eidos Therapeutics
Sep 18, 2020
Uninformative Sell
289.22K
$46.56M
Edgewise Therapeutics
Nov 13, 2025
Director
Informative Buy
199.34K
$527.61K
List of latest transactions for each holding click on a transaction to see Jonathan C Fox's performance on stock

Jonathan C Fox insider profile FAQ

What is the percentage of profitable transactions made by Jonathan C Fox?
The percentage of profitable transactions made by Jonathan C Fox is 9%.
    What is the average return per transaction made by Jonathan C Fox?
    The average return per transaction made by Jonathan C Fox is -51.50%.
      What stocks does Jonathan C Fox hold?
      Jonathan C Fox holds: EIDX, EWTX stocks.
        What was Jonathan C Fox’s latest transaction?
        Jonathan C Fox latest transaction was an Informative Buy of $199.34K.
          What was Jonathan C Fox's most profitable transaction?
          Jonathan C Fox’s most profitable transaction was an Informative Buy of EWTX stock on December 28, 2023. The return on the trade was 149.90%.
            What is Jonathan C Fox's role in Eidos Therapeutics?
            Jonathan C Fox's role in Eidos Therapeutics is President and Chief Medical Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.